Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Alnylam’s hemophilia drug appears to lower frequency of bleeding in early study
Alnylam’s hemophilia drug appears to lower frequency of bleeding in early study
Alnylam’s hemophilia drug appears to lower frequency of bleeding in early study
Submitted by
admin
on December 7, 2015 - 12:13pm
Source:
Bizjournals.com
News Tags:
Alnylam
fitusiran
hemophilia
Headline:
Alnylam’s hemophilia drug appears to lower frequency of bleeding in early study
Do Not Allow Advertisers to Use My Personal information
